Literature DB >> 7030514

Myocardial composition and function in diabetes. The effects of chronic insulin use.

T J Regan, C F Wu, C K Yeh, H A Oldewurtel, B Haider.   

Abstract

This study was undertaken in an animal model of mild diabetes to determine if provision of chronic insulin replacement during postprandial hyperglycemia may modify the abnormalities of myocardium. Group 1 served as controls with normal glucose tolerance by intravenous testing. Two additional groups were made diabetic with low doses of alloxan. Diabetic animals of Group 2 were untreated (n = 6). Group 3 animals (n = 6) received regular insulin daily to reduce postprandial hyperglycemia. After one year with maintained body weight, the animals were studied in the intact anesthetized state using the indicator dilution technique for left ventricular volume determinations. Basal left ventricular function and contractility were similar to normals in both diabetic groups. During intraventricular infusion of saline, end-diastolic pressure rose to higher levels in untreated diabetes (14.8 +/- 2 mm Hg) than normals (8.8 +/- 0.84), despite similar basal levels. Insulin treatment was associated with higher filling pressures than in group 1 as well as reduced end-diastolic volume response. Collagen concentrations were enhanced an average of 50% in layers from the inner to outer myocardium in both untreated and treated diabetics, associated with sodium and water accumulation. Since hypertrophy was not present, the diminished compliance appeared related to increased collagen levels. On electron microscopy, the subcellular organelles of the cardiac cell appeared normal in both diabetic groups. Thus, collagen accumulation and abnormal myocardial function in this model of diabetes is not affected by control of postprandial hyperglycemia, but a potential role for sustained hormone replacement is not excluded.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7030514     DOI: 10.1161/01.res.49.6.1268

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  31 in total

1.  Magnetic resonance imaging analysis of cardiac cycle events in diabetic rats: the effect of angiotensin-converting enzyme inhibition.

Authors:  Ahmad I M Al-Shafei; R G Wise; G A Gresham; T A Carpenter; L D Hall; Christopher L H Huang
Journal:  J Physiol       Date:  2002-01-15       Impact factor: 5.182

Review 2.  The mTOR Signaling Pathway in Myocardial Dysfunction in Type 2 Diabetes Mellitus.

Authors:  Tomohiro Suhara; Yuichi Baba; Briana K Shimada; Jason K Higa; Takashi Matsui
Journal:  Curr Diab Rep       Date:  2017-06       Impact factor: 4.810

Review 3.  The heart in diabetes.

Authors:  D J Kereiakes; J L Naughton; B Brundage; N B Schiller
Journal:  West J Med       Date:  1984-04

4.  Alterations in Ca2+ binding by and composition of the cardiac sarcolemmal membrane in chronic diabetes.

Authors:  G N Pierce; M J Kutryk; N S Dhalla
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

Review 5.  Role of extracellular matrix proteins in heart function.

Authors:  V Pelouch; I M Dixon; L Golfman; R E Beamish; N S Dhalla
Journal:  Mol Cell Biochem       Date:  1993-12-22       Impact factor: 3.396

6.  Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory.

Authors:  S Roy; R Sala; E Cagliero; M Lorenzi
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

Review 7.  Diabetic cardiomyopathy.

Authors:  F S Fein; E H Sonnenblick
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

8.  Increased rat myocardial type VI collagen in diabetes mellitus and hypertension.

Authors:  M J Spiro; T J Crowley
Journal:  Diabetologia       Date:  1993-02       Impact factor: 10.122

9.  Arrhythmia susceptibility and myocardial composition in diabetes. Influence of physical conditioning.

Authors:  S Bakth; J Arena; W Lee; R Torres; B Haider; B C Patel; M M Lyons; T J Regan
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

Review 10.  Diabetic cardiomyopathy.

Authors:  Omar Asghar; Ahmed Al-Sunni; Kaivan Khavandi; Ali Khavandi; Sarah Withers; Adam Greenstein; Anthony M Heagerty; Rayaz A Malik
Journal:  Clin Sci (Lond)       Date:  2009-05       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.